CVRx is focused on the development and commercialization of the Barostim™ System, the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of heart failure.
Products and Services Information
Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. Baroreceptors activate the body’s baroreflex, which in turn triggers an autonomic response to the heart. The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure. Barostim received the FDA Breakthrough Device designation and is FDA-approved for use in heart failure patients in the U.S.
Northwell Health’s Office of CME invites you to click the button below to claim and submit a raffle ticket for visiting this booth.
The more booths you visit and the more raffle tickets you submit, the greater your chances of winning. Only one submission per booth counts. Hope you win!
Please enter your name and email below to submit your virtual raffle ticket.
